REG - Haleon PLC - Board Change

HALEONAnnouncement

Yesterday 10:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250430:nRSd7124Ga&default-theme=true

RNS Number : 7124G  Haleon PLC  30 April 2025

Haleon plc: Board Change

 

30 April 2025: Haleon plc (the "Company" or "Haleon") today announces the
appointment of Matt Shattock as independent Non-Executive Director with effect
from 1 June 2025.

 

Matt brings significant innovation, operational and executive leadership
experience in consumer goods and retail to Haleon. Matt is currently the Lead
Independent Director of The Clorox Company and a non-executive director of VF
Corporation. Matt was previously the Chairman of Domino's Pizza Group plc from
2020 to 2025. He was also President and CEO of Beam Suntory Inc., from 2009 to
2020, where he led the successful integration of the Beam and Suntory spirits
businesses and delivered brand portfolio transformation and accelerated global
growth.

 

Sir Dave Lewis, Haleon's Chair commented: "On behalf of the Board, I would
like to welcome Matt to Haleon. Matt's track record in building innovative
brands, driving operational excellence and sustained value creation across
multiple global consumer businesses as well as his substantial knowledge of
the North American market will add significant strengths to our Board."

 

The Company confirms that there is no further information to be disclosed
under the requirements of UKLR 6.4.6R and 6.4.8R.

 

Amanda Mellor

Company Secretary

 

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAPKCBQFBKDNQB